Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. www.hhs.gov › immunization › diseasesYellow Fever | HHS.gov

    Yellow fever is common in parts of Africa and South America. In fact, in Africa about 180,000 people get it every year. Yellow fever is not found in the United States — and thanks to the vaccine, travelers rarely get the disease.\n\nThe yellow fever vaccine is only recommended for people living in or traveling to places where yellow fever is a risk — or for people who work in labs studying ...

  2. During the period 12 January to 15 March 2022, a total of 53 suspected yellow fever cases, including six deaths, have been reported from Isiolo county, central Kenya. Two samples tested positive by RT-PCR and six were positive by ELISA, indicating probable yellow fever cases. The last reported yellow fever outbreak in Kenya was in 2011. WHO assesses the public health risk as high at the ...

  3. 18 de nov. de 2022 · Overview . The Country List is a compilation of key information to facilitate international travel. The information provided for each country includes vaccination requirements for international travellers as provided by States Parties to the International Health Regulations (2005) (IHR), as well as WHO recommendations for vaccination against yellow fever, poliomielytis, and malaria prophylaxis.

  4. Yellow fever (YF) cause a wide spectrum of symptoms, from mild to fatal. In severe cases there may be spontaneous haemorrhage. Mortality of these clinical cases can be as high as 80%, on a par with Ebola, Marburg and other haemorrhagic viral infections.

  5. 6 The risk of yellow fever transmission is present only in parts of the country. For details, refer to the WHO International Travel and Health Country List (2022). 7 The list of countries these requirements apply differs from that of countries determined by WHO to be at risk for yellow fever transmission.

  6. A single dose of yellow fever vaccine should provide lifelong immunity in most healthy adults and children. Protective levels of neutralising antibodies have been detected in 75–100% of healthy adults from endemic and non- endemic yellow fever areas when measured 10–69 years after the 1st vaccination. 3-5.

  7. Yellow fever is an epidemic-prone vector-borne vaccine preventable viral disease that is transmitted to humans by the bites of infected mosquitos. In some of the unvaccinated individuals, the virus can cause severe illness including jaundice and bleeding (severe cases).

  1. Otras búsquedas realizadas